A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)
Phase 3
Terminated
- Conditions
- Diabetic Neuropathy, PainfulDiabetic Polyneuropathy
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2014-03-04
- Target Recruit Count
- 47
- Registration Number
- NCT01063868
Concomitant Use of PriLigy in Men Treated for Erectile Dysfunction
Phase 3
Completed
- Conditions
- Erectile DysfunctionSexual Dysfunction
- Interventions
- First Posted Date
- 2010-02-05
- Last Posted Date
- 2013-01-24
- Target Recruit Count
- 495
- Registration Number
- NCT01063855
A Study to Evaluate the Pain Relieving Effects, Safety, and Tolerability of JNJ-42160443 for the Relief of Bladder Pain
Phase 2
Terminated
- Conditions
- Cystitis, InterstitialUrologic DiseasesUrinary Bladder DiseasesCystitis
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2021-10-18
- Target Recruit Count
- 31
- Registration Number
- NCT01060254
A Drug Interaction Study of Valproic Acid and Single-dose Paliperidone Extended-Release (ER) in Healthy Men
Phase 1
Completed
- Conditions
- EpilepsySchizophrenia
- Interventions
- Drug: divalproex sodium ER
- First Posted Date
- 2010-02-02
- Last Posted Date
- 2012-12-24
- Target Recruit Count
- 24
- Registration Number
- NCT01060228
A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy Volunteers
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2013-09-04
- Target Recruit Count
- 120
- Registration Number
- NCT01054014
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
Phase 1
Completed
- Conditions
- Diabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2013-09-04
- Target Recruit Count
- 18
- Registration Number
- NCT01054118
A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal Allergies
Phase 1
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: JNJ38224342/placebo
- First Posted Date
- 2010-01-22
- Last Posted Date
- 2013-09-04
- Target Recruit Count
- 182
- Registration Number
- NCT01054352
A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in Children
Phase 4
Completed
- Conditions
- SchizophreniaBipolar DisorderAutistic DisorderConduct and Other Disruptive Behavior Disorders
- Interventions
- Drug: Other atypical antipsychotic drugs
- First Posted Date
- 2010-01-15
- Last Posted Date
- 2012-11-27
- Target Recruit Count
- 244
- Registration Number
- NCT01050582
A Study to Evaluate the Efficacy, Safety, and Tolerability of Tapentadol ER Compared With Placebo in Patients With Chronic, Painful Diabetic Peripheral Neuropathy
Phase 3
Completed
- Conditions
- Diabetic Peripheral Neuropathy
- Interventions
- Drug: Placebo
- First Posted Date
- 2010-01-01
- Last Posted Date
- 2013-09-11
- Target Recruit Count
- 460
- Registration Number
- NCT01041859
A Study of the Safety of R256918 in Obese Patients
Phase 2
Completed
- Conditions
- ObesityNutritional and Metabolic DiseasesMetabolic DiseasesNutrition DisordersOverweight
- Interventions
- Drug: placebo
- First Posted Date
- 2010-01-01
- Last Posted Date
- 2013-01-24
- Target Recruit Count
- 71
- Registration Number
- NCT01041677
© Copyright 2025. All Rights Reserved by MedPath